Caricamento...
Placebo controlled pilot trial to study the remyelinating potential of intravenous immunoglobulins in multiple sclerosis
Currently there is no treatment available to improve a stable deficit in multiple sclerosis. It was shown in animal models that intravenous immunoglobulins (IVIg) can enhance central nervous remyelination, and the first open trials were promising. We therefore conducted a double blind, placebo contr...
Salvato in:
| Autori principali: | , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMJ Group
2000
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1760582/ https://ncbi.nlm.nih.gov/pubmed/10601410 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp.68.1.89 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|